| 4 | Statement of changes in beneficial owner... | Ligand Pharmaceuticals Inc | Dorica De La Fuente, Inc. Dba Financial Intelligence /fa | 06/09/2026 | |
| 4 | Statement of changes in beneficial owner... | Gray Nancy Ryan | | 06/09/2026 | |
| 4 | Statement of changes in beneficial owner... | Ligand Pharmaceuticals Inc | Dorica De La Fuente, Inc. Dba Financial Intelligence /fa | 11/12/2025 | |
| 4 | Statement of changes in beneficial owner... | Gray Nancy Ryan | Dorica De La Fuente, Inc. Dba Financial Intelligence /fa | 11/12/2025 | |
| 144 | Filing for proposed sale of securities u... | Ligand Pharmaceuticals Inc | Morgan Stanley Smith Barney Llc Executive Services /fa | 11/07/2025 | |
| 144 | Filing for proposed sale of securities u... | Gray Nancy Ryan | Morgan Stanley Smith Barney Llc Executive Services /fa | 11/07/2025 | |
| 4 | Statement of changes in beneficial owner... | Ligand Pharmaceuticals Inc | Dorica De La Fuente, Inc. Dba Financial Intelligence /fa | 06/10/2025 | |
| 4 | Statement of changes in beneficial owner... | Gray Nancy Ryan | Dorica De La Fuente, Inc. Dba Financial Intelligence /fa | 06/10/2025 | |
| 4 | Statement of changes in beneficial owner... | Ligand Pharmaceuticals Inc | Financial Intelligence, Llc /fa | 06/18/2024 | |
| 4 | Statement of changes in beneficial owner... | Gray Nancy Ryan | Financial Intelligence, Llc /fa | 06/18/2024 | |
| Load More |